Author: Carly Behm

Deepak Reddy, MD, of South Bend (Ind.) Orthopedics completed the first solo SynerFuse procedure.

Curiteva received FDA 510(k) approval for its pedicle and sacroiliac joint navigation instruments, the medtech company said Aug. 8.

Two spine surgeons were cleared of malpractice allegations in the last month.

EpiBone named Brian Cole, MD, of Chicago-based Rush University Medical Center, as an adviser, the regenerative medicine company said Aug. 8.

Several orthopedic surgeons in 2023 are suing their former employers for various concerns including alleged discrimination, fraud and monopolies.

Theradaptive and 3D Systems are partnering to bolster regenerative medicine, according to an Aug. 7 news release. 

Alphatec posted $117 million in second quarter sales.

SynerFuse named Bill Koschak as CFO, the company said Aug. 7.

New York City-based Hospital for Special Surgery named Answorth Allen, MD, and Mathias Bostrom, MD, as associate surgeons-in-chief.

Stabilizing the revenue cycle was the first priority for Ed Tufaro, interim CEO of Philadelphia-based Rothman Orthopaedic Institute, Philadelphia Business Journal reported Aug. 7.